Avantis takes $1.4M to diagnose colon cancer
Avantis Medical Systems, a biotech company that makes a device used to detect colon cancer, has brought in $1.4 million of an anticipated $4 million round of debt, rights and securities, according to a filing with the SEC. Based in Sunnyvale Calif., it...

EmSense, the company that reads your brain’s reactions to ads, gets boost
EmSense — the San Francisco company that has created a device to read your mind to assess how you react to TV commercials and other media — has raised $9 million more in a third round of funding.The company says it is trying to improve on...

NEA rakes in $2.5B for new fund
New Enterprise Associates, which remains the largest venture firm in the business, announced that it is closing in on its $2.5 billion target for its new fund, its thirteenth, reports Dow Jones VentureWire. The firm says it will keep the fund open for a...

VentureBeat’s policy on embargoes: We’ll take ‘em
In the news business, there’s something called an embargo. That’s when a company, usually through a public relations person, gets an agreement from a writer not to publish a story until a certain time. The writer is then allowed access to people and...